Literature DB >> 11032966

A survey of calpain inhibitors.

I O Donkor1.   

Abstract

Calpain is unique among the cysteine protease family of enzymes in that it combines thiol protease activity with calmodulin-like activity. Despite its wide spread distribution the exact physiological function(s) of calpain is yet to be deciphered. The enzyme is however, implicated in a number of pathophysiological conditions. Due to the potential of calpain as a therapeutic target a number of inhibitors have been described for the enzyme. In this article we have grouped calpain inhibitors into those derived from natural sources, and those derived from chemical synthesis. Additionally, an overview of functional groups that have been used as warheads of calpain inhibitors is presented along with a discussion of the structure activity relationship studies of the address region of peptidyl calpain inhibitors. Recent work in this area has led to a better understanding of the structural requirements for tight binding of inhibitors to the active site of calpain. A discussion of peptidomimetic calpain inhibitors, nonpeptide calpain inhibitors, and selectivity of some calpain inhibitors are also presented. The recent disclosure of the crystal structure of a nonpeptide calpain inhibitor bound to a hydrophobic pocket on the calcium-binding domain of calpain has opened the door to future development of potent cell permeable nonpeptide calpain inhibitors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11032966     DOI: 10.2174/0929867003374129

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  20 in total

1.  Regulation of lck degradation and refractory state in CD8+ cytotoxic T lymphocytes.

Authors:  Michael Uhlin; Maria G Masucci; Victor Levitsky
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-15       Impact factor: 11.205

2.  Use of recombinant calpain-2 siRNA adenovirus to assess calpain-2 modulation of lung endothelial cell migration and proliferation.

Authors:  Kai Qiu; Yunchao Su; Edward R Block
Journal:  Mol Cell Biochem       Date:  2006-05-30       Impact factor: 3.396

Review 3.  The role of calcium-activated protease calpain in experimental retinal pathology.

Authors:  M Azuma; T R Shearer
Journal:  Surv Ophthalmol       Date:  2008 Mar-Apr       Impact factor: 6.048

4.  Synthesis and calpain inhibitory activity of peptidomimetic compounds with constrained amino acids at the P2 position.

Authors:  Isaac O Donkor; Rajani Korukonda
Journal:  Bioorg Med Chem Lett       Date:  2008-07-27       Impact factor: 2.823

5.  Disruption of the axon initial segment cytoskeleton is a new mechanism for neuronal injury.

Authors:  Dorothy P Schafer; Smita Jha; Fudong Liu; Trupti Akella; Louise D McCullough; Matthew N Rasband
Journal:  J Neurosci       Date:  2009-10-21       Impact factor: 6.167

6.  Identification and optimization of a novel inhibitor of mitochondrial calpain 10.

Authors:  Kyle A Rasbach; David D Arrington; Sina Odejinmi; Chris Giguere; Craig C Beeson; Rick G Schnellmann
Journal:  J Med Chem       Date:  2009-01-08       Impact factor: 7.446

7.  Limitations of SLLVY-AMC in calpain and proteasome measurements.

Authors:  Christopher J Giguere; Rick G Schnellmann
Journal:  Biochem Biophys Res Commun       Date:  2008-05-05       Impact factor: 3.575

8.  Identification of small molecule inhibitors of beta-amyloid cytotoxicity through a cell-based high-throughput screening platform.

Authors:  K I Seyb; E R Schuman; J Ni; M M Huang; M L Michaelis; M A Glicksman
Journal:  J Biomol Screen       Date:  2008-09-23

9.  Cocrystal structures of primed side-extending alpha-ketoamide inhibitors reveal novel calpain-inhibitor aromatic interactions.

Authors:  Jin Qian; Dominic Cuerrier; Peter L Davies; Zhaozhao Li; James C Powers; Robert L Campbell
Journal:  J Med Chem       Date:  2008-08-15       Impact factor: 7.446

10.  Structural basis for the potent calpain inhibitory activity of peptidyl alpha-ketoacids.

Authors:  Isaac O Donkor; Haregewein Assefa; Jiuyu Liu
Journal:  J Med Chem       Date:  2008-07-24       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.